These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 21785087)

  • 1. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging in localizing tumors.
    Tamada T; Sone T; Jo Y; Hiratsuka J; Higaki A; Higashi H; Ito K
    AJR Am J Roentgenol; 2011 Aug; 197(2):408-14. PubMed ID: 21785087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
    Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
    AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.
    Kim CK; Park BK; Lee HM; Kim SS; Kim E
    AJR Am J Roentgenol; 2008 May; 190(5):1180-6. PubMed ID: 18430829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience.
    Kim CK; Park BK; Park W; Kim SS
    Abdom Imaging; 2010 Apr; 35(2):246-52. PubMed ID: 19130116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.
    Roy C; Foudi F; Charton J; Jung M; Lang H; Saussine C; Jacqmin D
    AJR Am J Roentgenol; 2013 Apr; 200(4):W361-8. PubMed ID: 23521479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences.
    Moman MR; van den Berg CA; Boeken Kruger AE; Battermann JJ; Moerland MA; van der Heide UA; van Vulpen M
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):741-6. PubMed ID: 19804948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
    Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
    AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
    Quentin M; Arsov C; Röhlen S; Klasen J; Antoch G; Albers P; Blondin D
    Rofo; 2012 Oct; 184(10):925-9. PubMed ID: 22744328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
    Kim CK; Park BK; Lee HM
    J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
    Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
    AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
    Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
    Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
    J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
    Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
    J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.
    Kara T; Akata D; Akyol F; Karçaaltıncaba M; Özmen M
    Diagn Interv Radiol; 2011 Mar; 17(1):38-43. PubMed ID: 20703995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
    Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
    J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
    Kim CK; Park BK; Lee HM; Kwon GY
    Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.